The Alzheimer’s Association has published an analysis of a 2024 RAND report that outlines the health, community, and economic benefits of more systemic and deliberate investment in the treatment of Alzheimer’s disease in adults with Down syndrome.
The Alzheimer’s Association has published an analysis of a 2024 RAND report that outlines the health, community, and economic benefits of more systemic and deliberate investment in the treatment of Alzheimer’s disease in adults with Down syndrome.
CDC’s Childhood Lead Poisoning Prevention Program is dedicated to reducing childhood lead poisoning as a public health problem through strengthening blood
10/1/2024 | For immediate release | Contact: Kate O’Neill ([email protected]) Investment in Alzheimer’s Research Today Will Yield Health Benefits for
Project will empower advocates, enhance research for people at high risk of Alzheimer’s disease who have Down syndrome Washington, D.C.
Dental care is important for everybody, but people with Down syndrome can have a number of differences that can require
FDA issues approval for Kisunla, new Alzheimer’s drug; Down syndrome community optimistic On Tuesday, July 2, the U.S. Food and
Major pharmaceutical company announces Down syndrome population will see a clinical trial of new Alzheimer’s drug People with Down syndrome
The physicians of the Adult Down Syndrome Center recommend that individuals with Down syndrome ages 12 years and older who
Individuals with Down syndrome (DS) may be more susceptible to oral disorders as a result of a combination of genetic
